{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:32:27Z","timestamp":1773891147885,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:00:00Z","timestamp":1795132800000},"content-version":"am","delay-in-days":292,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","award":["R01HL171282"],"award-info":[{"award-number":["R01HL171282"]}],"id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018268","name":"Children&apos;s Miracle Network Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["R01 R01HL171282"],"award-info":[{"award-number":["R01 R01HL171282"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Physiology &amp; Neurobiology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.resp.2025.104513","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T22:12:33Z","timestamp":1763590353000},"page":"104513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["AAV9 gene therapy to target respiratory insufficiency in the D2.mdx mouse model of duchenne muscular dystrophy"],"prefix":"10.1016","volume":"340","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-0149","authenticated-orcid":false,"given":"Debolina D.","family":"Biswas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas H.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00e1n Y.","family":"Hern\u00e1ndez Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarra M.","family":"Abdelbarr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn R.","family":"Scarrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1775-1156","authenticated-orcid":false,"given":"Mai K.","family":"ElMallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resp.2025.104513_bib1","unstructured":"Administration, U. S. F. a. D. FDA approves first gene therapy for treatment of certain patients with Duchenne muscular dystrophy, <https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapy-treatment-certain-patients-duchenne-muscular-dystrophy> (2023)."},{"key":"10.1016\/j.resp.2025.104513_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.prrv.2009.10.002","article-title":"Pulmonary complications of neuromuscular disease: a respiratory mechanics perspective","volume":"11","author":"Allen","year":"2010","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.resp.2025.104513_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejpn.2007.08.009","article-title":"Swallowing difficulties in Duchenne muscular dystrophy: indications for feeding assessment and outcome of videofluroscopic swallow studies","volume":"12","author":"Aloysius","year":"2008","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.resp.2025.104513_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.chest.2021.08.078","article-title":"Characterizing expiratory respiratory muscle degeneration in duchenne muscular dystrophy using MRI","volume":"161","author":"Barnard","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.resp.2025.104513_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo1815","article-title":"Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy","volume":"15","author":"Birch","year":"2023","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.resp.2025.104513_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/1566523215666150630121750","article-title":"The skeletal muscle environment and its role in immunity and tolerance to AAV vector-mediated gene transfer","volume":"15","author":"Boisgerault","year":"2015","journal-title":"Curr. gene Ther."},{"key":"10.1016\/j.resp.2025.104513_bib7","doi-asserted-by":"crossref","first-page":"e2304","DOI":"10.1212\/WNL.0000000000012910","article-title":"Life expectancy in Duchenne muscular dystrophy: reproduced individual patient data meta-analysis","volume":"97","author":"Broomfield","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.resp.2025.104513_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098174","article-title":"Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy","volume":"24","author":"Cernisova","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.resp.2025.104513_bib9","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ymthe.2017.02.019","article-title":"Progress toward gene therapy for Duchenne muscular dystrophy","volume":"25","author":"Chamberlain","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.resp.2025.104513_bib10","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/1440-1681.12453","article-title":"Targeting transgene to the heart and liver with AAV9 by different promoters","volume":"42","author":"Chen","year":"2015","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"10.1016\/j.resp.2025.104513_bib11","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1038\/s41598-017-05993-8","article-title":"Utrophin compensates dystrophin loss during mouse spermatogenesis","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.resp.2025.104513_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/hmg\/ddv460","article-title":"Effect of genetic background on the dystrophic phenotype in mdx mice","volume":"25","author":"Coley","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.resp.2025.104513_bib13","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.resp.2025.104513_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.resp.2025.104513_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/343180a0","article-title":"Very mild muscular dystrophy associated with the deletion of 46% of dystrophin","volume":"343","author":"England","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.resp.2025.104513_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of AAV gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.resp.2025.104513_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/hmg\/11.7.733","article-title":"Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude\/mdx mice","volume":"11","author":"Fabb","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.resp.2025.104513_bib18","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/mt.2013.96","article-title":"Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease","volume":"21","author":"Falk","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.resp.2025.104513_bib19","unstructured":"FDA. delandistrogene moxep0061rvovec-rokl. Sarepta. (2023)."},{"key":"10.1016\/j.resp.2025.104513_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.23819","article-title":"LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy","volume":"73","author":"Flanigan","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.resp.2025.104513_bib21","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.2353\/ajpath.2010.090887","article-title":"Genetic background affects properties of satellite cells and mdx phenotypes","volume":"176","author":"Fukada","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.resp.2025.104513_bib22","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.048893","article-title":"Respiratory dysfunction in a mouse model of spinocerebellar ataxia type 7","volume":"14","author":"Fusco","year":"2021","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.resp.2025.104513_bib23","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/j.2040-4603.2015.tb00638.x","article-title":"The Dystrophin Complex: structure, function and implications for therapy","volume":"5","author":"Gao","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.resp.2025.104513_bib24","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1085","article-title":"Systemic delivery of genes to striated muscles using adeno-associated viral vectors","volume":"10","author":"Gregorevic","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.resp.2025.104513_bib25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nm1439","article-title":"rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice","volume":"12","author":"Gregorevic","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.resp.2025.104513_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.omtm.2017.06.006","article-title":"A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA\/2J-mdx Model of Duchenne Muscular Dystrophy","volume":"6","author":"Hakim","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.resp.2025.104513_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70987-y","article-title":"The D2. mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy","volume":"10","author":"Hammers","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.resp.2025.104513_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nm0302-253","article-title":"Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy","volume":"8","author":"Harper","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.resp.2025.104513_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0316295","article-title":"Respiratory pathology in the mdx\/utrn -\/- mouse: a murine model for Duchenne Muscular Dystrophy (DMD)","volume":"20","author":"Hern\u00e1ndez Rodr\u00edguez","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.resp.2025.104513_bib30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.resp.2025.104513_bib31","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","article-title":"The neurotropic properties of AAV-PHP. B are limited to C57BL\/6J mice","volume":"26","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.resp.2025.104513_bib32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1089\/hum.2008.162","article-title":"Efficient and fast functional screening of microdystrophin constructs in vivo and in vitro for therapy of duchenne muscular dystrophy","volume":"20","author":"J\u00f8rgensen","year":"2009","journal-title":"Hum. gene Ther."},{"key":"10.1016\/j.resp.2025.104513_bib33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.omtm.2019.12.007","article-title":"Intralingual and intrapleural AAV gene therapy prolongs survival in a SOD1 ALS mouse model","volume":"17","author":"Keeler","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.resp.2025.104513_bib34","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/mt.2010.94","article-title":"Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs","volume":"18","author":"Kornegay","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.resp.2025.104513_bib35","unstructured":"Laboratory, T.J. nd. D2.MDX PHYSIOLOGICAL DATA, <https:\/\/www.jax.org\/jax-mice-and-services\/solutions-by-therapeutic-area\/neurobiology\/muscular-dystrophy-efficacy-studies\/d2-mdx>"},{"key":"10.1016\/j.resp.2025.104513_bib36","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI36612","article-title":"Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy","volume":"119","author":"Lai","year":"2009","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.resp.2025.104513_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16105","article-title":"Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy","volume":"8","author":"Le Guiner","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.resp.2025.104513_bib38","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/hmg\/ddp015","article-title":"Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice","volume":"18","author":"Li","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.resp.2025.104513_bib39","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1089\/hum.2020.065","article-title":"Intralingual Administration of AAVrh10-miR SOD1 Improves Respiratory But Not Swallowing Function in a Superoxide Dismutase-1 Mouse Model of Amyotrophic Lateral Sclerosis","volume":"31","author":"Lind","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.resp.2025.104513_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.resp.2020.103525","article-title":"Respiratory pathology in the Optn(-\/-) mouse model of Amyotrophic Lateral Sclerosis","volume":"282","author":"McCall","year":"2020","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.resp.2025.104513_bib41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1242\/dmm.018424","article-title":"Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy","volume":"8","author":"McGreevy","year":"2015","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.resp.2025.104513_bib42","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial","volume":"77","author":"Mendell","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.resp.2025.104513_bib43","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1113\/JP281671","article-title":"Breathing in Duchenne muscular dystrophy: translation to therapy","volume":"600","author":"Mhandire","year":"2022","journal-title":"J. Physiol."},{"key":"10.1016\/j.resp.2025.104513_bib44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00005072-199701000-00010","article-title":"Preferential subsarcolemmal localization of dystrophin and \u03b2-dystroglycan mRNA in human skeletal muscles","volume":"56","author":"Mitsui","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.resp.2025.104513_bib45","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/d41573-021-00164-x","article-title":"Gene therapy community grapples with toxicity issues, as pipeline matures","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.resp.2025.104513_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1101\/lm.053527.121","article-title":"Dysregulation of Npas4 and Inhba expression and an altered excitation-inhibition balance are associated with cognitive deficits in DBA\/2 mice","volume":"29","author":"Oberl\u00e4nder","year":"2022","journal-title":"Learn Mem."},{"key":"10.1016\/j.resp.2025.104513_bib47","first-page":"121","article-title":"Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients","volume":"31","author":"Passamano","year":"2012","journal-title":"Acta Myol."},{"key":"10.1016\/j.resp.2025.104513_bib48","article-title":"After Patient Death, FDA Places Hold on Pfizer Duchenne Muscular Dystrophy Gene Therapy Trial","volume":"33","author":"Philippidis","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.resp.2025.104513_bib49","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1164\/ajrccm.164.12.2103052","article-title":"Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy","volume":"164","author":"Phillips","year":"2001","journal-title":"Am. J. Respir. Crit. care Med."},{"key":"10.1016\/j.resp.2025.104513_bib50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/hum.2019.255","article-title":"Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.micro-dystrophin in the mdx Mouse Model of Duchenne Muscular Dystrophy","volume":"32","author":"Potter","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.resp.2025.104513_bib51","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1517\/21678707.2015.1088780","article-title":"Gene therapy for Duchenne muscular dystrophy","volume":"3","author":"Ramos","year":"2015","journal-title":"Expert Opin. orphan Drugs"},{"key":"10.1016\/j.resp.2025.104513_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.resp.2024.104282","article-title":"Respiratory characterization of a humanized Duchenne muscular dystrophy mouse model","volume":"326","author":"Roger","year":"2024","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.resp.2025.104513_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.resp.2025.104513_bib54","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0006-291X(02)00362-5","article-title":"Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene","volume":"293","author":"Sakamoto","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.resp.2025.104513_bib55","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1113\/EP087887","article-title":"Nutraceutical and pharmaceutical cocktails did not preserve diaphragm muscle function or reduce muscle damage in D2-mdx mice","volume":"105","author":"Spaulding","year":"2020","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.resp.2025.104513_bib56","doi-asserted-by":"crossref","unstructured":"Systemic Delivery of AAVB1-GAA Clears Glycogen and Prolongs Survival in a Mouse Model of Pompe Disease. Human Gene Therapy 30, 57-68 (2019). 10.1089\/hum.2018.016.","DOI":"10.1089\/hum.2018.016"},{"key":"10.1016\/j.resp.2025.104513_bib57","article-title":"Duchenne muscular dystrophy","author":"Venugopal","year":"2023","journal-title":"StatPearls"},{"key":"10.1016\/j.resp.2025.104513_bib58","doi-asserted-by":"crossref","first-page":"13714","DOI":"10.1073\/pnas.240335297","article-title":"Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model","volume":"97","author":"Wang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.resp.2025.104513_bib59","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s44321-024-00037-x","article-title":"Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor","volume":"16","author":"Xie","year":"2024","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.resp.2025.104513_bib60","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ymthe.2004.07.025","article-title":"AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype","volume":"10","author":"Yoshimura","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.resp.2025.104513_bib61","first-page":"3148","article-title":"[Introduction of rod-deleted dystrophin cDNA, delta DysM3, into mdx skeletal muscle using adenovirus vector]","volume":"55","author":"Yuasa","year":"1997","journal-title":"Nihon rinsho. Jpn. J. Clin. Med."},{"key":"10.1016\/j.resp.2025.104513_bib62","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1093\/hmg\/ddv310","article-title":"Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus","volume":"24","author":"Yue","year":"2015","journal-title":"Hum. Mol. Genet."}],"container-title":["Respiratory Physiology &amp; Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904825001247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904825001247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:35:30Z","timestamp":1773880530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569904825001247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":62,"alternative-id":["S1569904825001247"],"URL":"https:\/\/doi.org\/10.1016\/j.resp.2025.104513","relation":{},"ISSN":["1569-9048"],"issn-type":[{"value":"1569-9048","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV9 gene therapy to target respiratory insufficiency in the D2.mdx mouse model of duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Respiratory Physiology & Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resp.2025.104513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104513"}}